Immunomedics Inc
(IMMU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,127 | N/A | -17,496 | -9,893 | -6,466 |
| Depreciation Amortization | 443 | N/A | 1,055 | 745 | 373 |
| Other Working Capital | -1,802 | N/A | 233 | -533 | -1,434 |
| Other Operating Activity | 432 | 0 | 967 | 776 | 422 |
| Operating Cash Flow | $-6,054 | $N/A | $-15,241 | $-8,905 | $-7,105 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -193 | N/A | -398 | -361 | -312 |
| Sale Of Investment | N/A | N/A | 9,545 | 957 | 957 |
| Other Investing Activity | 0 | 0 | 251 | 100 | 100 |
| Investing Cash Flow | $-193 | $N/A | $9,398 | $696 | $745 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5 | N/A | 12 | 6 | 6 |
| Common Stock Repurchased | -27 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-22 | $N/A | $12 | $6 | $6 |
| Exchange Rate Effect | -179 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 27,098 | N/A | 29,533 | 29,533 | 29,533 |
| End Cash Position | 20,651 | N/A | 23,702 | 21,330 | 23,179 |
| Net Cash Flow | $-6,447 | $N/A | $-5,832 | $-8,204 | $-6,355 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,054 | N/A | -15,241 | -8,905 | -7,105 |
| Capital Expenditure | -193 | N/A | -398 | -361 | -312 |
| Free Cash Flow | -6,247 | 0 | -15,640 | -9,266 | -7,417 |